Trillium Therapeutics Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Trillium Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Trillium Therapeutics Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Option Exercise | M | 9.62 | 508 | 4,888 | 4,574 | |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Option Exercise | M | 3.31 | 2,604 | 8,629 | 54,688 | |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Option Exercise | M | 0.30 | 2,708 | 806 | 89,376 | |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Sell | S | 14.17 | 508 | 7,200 | 0 | 508 to 0 (-100.00 %) |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Buy | M | 9.62 | 508 | 4,888 | 508 | 0 to 508 |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Sell | S | 12.65 | 5,312 | 67,197 | 0 | 5.3 K to 0 (-100.00 %) |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Buy | M | 3.31 | 2,604 | 8,629 | 5,312 | 2.7 K to 5.3 K (+96.16 %) |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Petrova Penka | Chief Development O ... | Buy | M | 0.30 | 2,708 | 806 | 2,708 | 0 to 2.7 K |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Option Exercise | M | 9.62 | 584 | 5,619 | 5,260 | |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Option Exercise | M | 3.31 | 2,917 | 9,666 | 61,250 | |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Option Exercise | M | 0.30 | 3,646 | 1,085 | 120,313 | |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Sell | S | 14.12 | 584 | 8,248 | 0 | 584 to 0 (-100.00 %) |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Buy | M | 9.62 | 584 | 5,619 | 584 | 0 to 584 |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Sell | S | 12.65 | 6,563 | 83,022 | 0 | 6.6 K to 0 (-100.00 %) |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Buy | M | 3.31 | 2,917 | 9,666 | 6,563 | 3.6 K to 6.6 K (+80.01 %) |
| Feb 10 2021 | TRIL | Trillium Therapeut ... | Uger Robert | Chief Scientific Of ... | Buy | M | 0.30 | 3,646 | 1,085 | 3,646 | 0 to 3.6 K |